nach oben

Erschienen in:

03.06.2021 | original article

A1B and BB blood group genotypes are risk factors for pulmonary embolism

verfasst von: Tatjana Kereš, Irena Jukić, Tomo Svaguša, Ingrid Prkačin, Jasna Bingulac-Popović, Matea Vinković, Ana Hećimović, Marcela Živković, Nikolina Parašilovac

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2021

Einloggen, um Zugang zu erhalten

Summary

Background

Pulmonary embolism (PE) is a potentially life-threatening condition that mainly affects the people of advanced age. While certain blood group phenotypes (non‑O blood group) are known risk factors for the development of venous thromboembolism (VTE), there is no research which investigated the association of blood group genotypes with severity of PE. The aim of this study was to investigate the frequency of ABO blood group genotypes among the population of patients with PE and to investigate the correlation of the pulmonary embolism severity index (PESI) score to specific ABO blood group genotypes.

Material and methods

In this cross-sectional study 74 patients with PE diagnosed using CT pulmonary angiography were included and 303 blood donors without VTE or congenital thrombophilia participated as a control group. After isolation of genomic DNA ABO blood group genotype was determined using the polymerase chain reaction sequence-specific amplification (PCR-SSP) method.

Results

We observed a significantly higher frequency of A1B and BB genotypes in patients with PE compared to healthy individuals (A1B 14.9% vs. 4.3%, P < 0.001; BB 5.4% vs. 0.7%, P = 0.004), while the O1O1 genotype was significantly less frequent in patients (24.3% vs. 37.3%, P = 0.036). Analyzing the severity of the clinical presentation according to the PESI score, we did not find a correlation between the severity of the clinical presentation and a certain blood type genotype.

Conclusion

Patients with A1B and BB blood type genotype were at increased risk for developing pulmonary embolism, while patients with O1O1 genotype had a significantly lower risk of developing PE.

Vorheriger Artikel Association of digoxin therapy with case fatality rate in acute pulmonary embolism

Nächster Artikel Static and dynamic balance impairment and relationship with disease-related factors in patients with chronic obstructive pulmonary disease

ESC. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(543):603. https://doi.org/10.1093/eurheartj/ehz405.CrossRef

Pun VC, Hart JE, Kabrhel C, Camargo CA Jr, Baccarelli AA, Laden F. Prospective study of ambient particulate matter exposure and risk of pulmonary embolism in the nurses’ health study cohort. Environ Health Perspect. 2015;123(12):1265–70. https://doi.org/10.1289/ehp.1408927.CrossRefPubMedPubMedCentral

Dentali F, Riva N, Turato S, et al. Pulmonary embolism severity index accurately predicts long-term mortality rate in patients hospitalized for acute pulmonary embolism. J Thromb Haemost. 2013;11(12):2103–10. https://doi.org/10.1111/jth.12420.CrossRefPubMed

Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383–9. https://doi.org/10.1001/archinternmed.2010.199.CrossRefPubMed

Erythropoulou-Kaltsidou A, Alkagiet S, Tziomalos K. New guidelines for the diagnosis and management of pulmonary embolism: Key changes. WJC. 2020;12(5):161–6. https://doi.org/10.4330/wjc.v12.i5.161.CrossRefPubMedPubMedCentral

Zhou XY, Ben SQ, Chen HL, Ni SS. The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis. Respir Res. 2012; https://doi.org/10.1186/1465-9921-13-111.CrossRefPubMedPubMedCentral

Wu O, Bayoumi N, Vickers MA, Clark PABO. (H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost. 2008;6(1):62–9. https://doi.org/10.1111/j.1538-7836.2007.02818.x.CrossRefPubMed

Clark P, Wu O. ABO blood groups and thrombosis: a causal association, but is there value in screening? Future Cardiol. 2011;7(2):191–201. https://doi.org/10.2217/fca.10.191.CrossRefPubMed

Franchini M, Capra F, Targher G, et al. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thrombosis J. 2007;5:14. https://doi.org/10.1186/1477-9560-5-14.CrossRef

10.

Wolpin BM, Kabrhel C, Varraso R, et al. Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies. Thromb Haemost. 2010;104(5):962–71. https://doi.org/10.1160/TH10-05-0312.CrossRefPubMedPubMedCentral

11.

Ward S, O’Sullivan J, O’Donnell JS. The relationship between ABO blood group, von Willebrand factor and primary hemostasis. Blood. 2020; https://doi.org/10.1182/blood.2020005843.CrossRefPubMedPubMedCentral

12.

Yamamoto F, Cid E, Yamamoto M, Blancher A. ABO research in the modern era of genomics. Transfus Med Rev. 2012;26(2):103–18. https://doi.org/10.1016/j.tmrv.2011.08.002.CrossRefPubMed

13.

Trégouët DA, Heath S, Saut N, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood. 2009;113(21):5298–303. https://doi.org/10.1182/blood-2008-11-190389.CrossRefPubMed

14.

Kullab GJ, Zaidi ARZ, Albaqmi S, Alajlan H, Alsheef MA. ABO Blood Groups and the Risk of Venous Thromboembolism (VTE) Among Saudi Patients at a Tertiary Care Hospital in Riyadh. Blood. 2019;134(Supplement_1):4926. https://doi.org/10.1182/blood-2019-128050.CrossRef

15.

Jukić I, Bingulac-Popović J, Samaržija M, Lampalo M, Hećimović A, Đogić V, et al. Distribution of main alleles of the ABO system of blood groups in the Croatian population. Acta Medica Croat. 2017;71(4):235–40.

16.

Song J, Chen F, Campos M, Bolgiano D, Houck K, Chambless LE, et al. Quantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC study of 11,673 subjects. PLoS ONE. 2015;10(8):e132626. https://doi.org/10.1371/journal.pone.0132626.CrossRefPubMedPubMedCentral

17.

Stowell SR, Stowell CP. Biologic roles of the ABH and Lewis histo-blood group antigens part II: thrombosis, cardiovascular disease and metabolism. Vox Sang. 2019;114(6):535–52. https://doi.org/10.1111/vox.12786.CrossRefPubMed

18.

Jukic I, Bingulac-Popovic J, Dogic V, et al. ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat Med J. 2009;50(6):550–8. https://doi.org/10.3325/cmj.2009.50.550.CrossRefPubMedPubMedCentral

19.

Konstantinides SV, Torbicki A, Agnelli G, et al. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–69k. https://doi.org/10.1093/eurheartj/ehu283. [published correction appears in Eur Heart J. 2015 Oct 14;36(39):2642]..CrossRefPubMed

20.

Gassner C, Schmarda A, Nussbaumer W, Schönitzer D. ABO glycosyltransferase genotyping by polymerase chain reaction using sequence-specific primers. Blood. 1996;88(5):1852–6.CrossRef

21.

Anstee DJ. The relationship between blood groups and disease. Blood. 2010;115(23):4635–43. https://doi.org/10.1182/blood-2010-01-261859.CrossRefPubMed

22.

Hajizadeh R, Kavandi H, Nadiri M, Ghaffari S. Association of ABO blood group with incidence and outcome of acute pulmonary embolism. Turk Kardiyol Dern Ars. 2016;44(5):397–403. https://doi.org/10.5543/tkda.2016.43996.CrossRefPubMed

23.

Ewald DR, Sumner SC. Blood type biochemistry and human disease. Wiley Interdiscip Rev Syst Biol Med. 2016;8(6):517–35. https://doi.org/10.1002/wsbm.1355.CrossRefPubMedPubMedCentral

24.

Murray GP, Post SR, Post GR. ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells. J Clin Pathol. 2020;73(6):347–9. https://doi.org/10.1136/jclinpath-2019-206182.CrossRefPubMed

25.

Franchini M, Makris M. Non‑O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus. 2013;11(2):164–5. https://doi.org/10.2450/2012.0087-12.CrossRefPubMedPubMedCentral

26.

Dubinski D, Keil F, Won SY, et al. Pulmonary embolism in neurocritical care-introduction of a novel grading system for risk stratification: the Frankfurt AMBOS score. Neurosurg Rev. 2020; https://doi.org/10.1007/s10143-020-01310-6.CrossRefPubMedPubMedCentral

Titel: A1B and BB blood group genotypes are risk factors for pulmonary embolism
verfasst von: Tatjana Kereš
Irena Jukić
Tomo Svaguša
Ingrid Prkačin
Jasna Bingulac-Popović
Matea Vinković
Ana Hećimović
Marcela Živković
Nikolina Parašilovac
Publikationsdatum: 03.06.2021
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 21-22/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-021-01882-3

Springer Medizin Österreich

Summary

Background

Material and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 21-22/2021

Veranstaltungstipps

Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma

Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer

Static and dynamic balance impairment and relationship with disease-related factors in patients with chronic obstructive pulmonary disease

New insights from GINA 2019/2020—Focus on early anti-inflammatory therapy

Correction to: Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma